Found 32 matching trials
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer PHASE2 This is a randomized trial for patients with metastatic hormone receptor (H...
Show More Location
University of Alabama at Birmingham (UAB)
Learn More & Join Trial
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer PHASE1 Investigators hypothesize that concurrent ribociclib treatment and chemothe...
Show More Location
University of Michigan Comprehensive Cancer Center
Learn More & Join Trial
A Deep Learning Method to Evaluate QT on Ribociclib N/A "Deep-learning" is a fast-growing method of machine learning (artificial in...
Show More Location
Groupe Ambroise Paré, Hartmann
Learn More & Join Trial
Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer PHASE1 This document outlines an investigator-initiated Phase Ib/II clinical trial...
Show More Location
Nagoya City University
Learn More & Join Trial
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics PHASE1 This is an open-label, multi-center, phase I study designed to assess the m...
Show More Location
Huntsman Cancer Institute
Learn More & Join Trial
Impact of Ribociclib on Head and Neck Squamous Cell Cancer EARLY_PHASE1 A window of opportunity study which would allow brief treatment of HPV nega...
Show More Location
Fox Chase Cancer Center
Learn More & Join Trial
Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative PHASE1 The proposed study is a multicenter, open-label phase I trial, conducted in...
Show More Location
Centre Leon Berard
Learn More & Join Trial
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer PHASE1 This is an open-label, FIH study designed to evaluate the maximum tolerated...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study PHASE3 The purpose of this study is to generate evidence on an alternative dosing ...
Show More Location
Ironwood Cancer & Research Centers
Learn More & Join Trial
A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) PHASE2 This is a multi-center, open-label Phase II randomized pre-surgical pharmac...
Show More Location
Highlands Oncology Group SC
Learn More & Join Trial